Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus

Toxicon

Volumn 36, Issue 11, 1998, Pages 1651-1658

  Bowersox, S Scott ^a   Luther, Robert ^a  

^a Neurex Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; OMEGA CONOTOXIN MVIIA; OPIATE;

ALLODYNIA; ANALGESIA; BRAIN ISCHEMIA; BRAIN SYNAPTOSOME; CALCIUM TRANSPORT; CANCER PAIN; CHRONIC PAIN; CONFERENCE PAPER; DEPOLARIZATION; DISULFIDE BOND; DOSE RESPONSE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; HIPPOCAMPUS; MOLECULAR SEQUENCE DATA; MOLLUSCA; MOLLUSK VENOMS; NEUROPROTECTIVE AGENTS; OMEGA-CONOTOXINS; PAIN MEASUREMENT; PEPTIDES; RATS;

EID: 0031796866     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00158-5     Document Type: Conference Paper

References (32)

1. Basus V. J., Nadasdi L., Ramachandran J., Miljanich G. P. Solution structure of ω-conotoxin MVIIA using 2D NMR spectroscopy. FEBS Lett. 370:1995;163-169.
2. Bowersox S. S., Gadbois T., Singh T., Pettus M., Wang Y.-X., Luther R. R. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 279:1996;1243-1249.
3. Bowersox S. S., Singh T., Luther R. R. Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Res. 747:1997;343-347.
4. Bowersox, S., Tich, N., Mayo, M. and Luther, R. (1998) SNX-111, a selective N-type voltage-sensitive calcium channel blocker: a new class of antinociceptive agent. Drugs of the Future 23(2), 152-160.
5. Brose W. G., Gutlove D. P., Luther R. R., Bowersox S. S., McGuire D. Use of intrathecal SNX-111, a novel N-type, voltage-sensitive calcium channel blocker, in the management of intractable brachial avulsion pain. Clin. J. Pain. 13:1997;256-259.
6. 2+ blocker prevents CA1 injury 24 h after severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
7. Choi D. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
8. Chung D., Gaur S., Bell J. R., Ramachandran J., Nadasdi L. Determination of disulfide bridge pattern in ω-conopeptides. Int. J. Peptide Protein Res. 46:1995;320-325.
9. Davis J. H., Bradley E. K., Miljanich G. P., Nadasdi L., Ramachandran J., Basus V. J. Solution structure of ω-conotoxin GVIA using 2D NMR spectroscopy and relaxation matrix analysis. Biochemistry. 27:1993;7396-7405.
10. 1H NMR spectroscopy and complete relaxation matrix analysis J. Mol. Biol. 248:1995;106-124.
11. Gohil K., Bell J. R., Ramachandran J., Miljanich G. P. Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium channel antagonist, SNX-230 (ω-conopeptide MVIIC). Brain Res. 653:1994;258-266.
12. 2+ diversity. Annu. Rev. Neurosci. 17:1994;399-418.
13. 45c alcium accumulation Acta Neurochir. Suppl. 60:1994;521-523.
14. Kim S. H., Chung J. M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
15. Kristipati R., Nadasdi L., Tarczy-Hornoch K., Lau K., Miljanich G. P., Ramachandran J., Bell J. R. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels. Mol. Cell Neurosci. 5:1994;219-228.
16. Malmberg A. B., Yaksh T. L. Effect of continuous intrathecal infusion of ω-conopeptides, N-type calcium channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain. 60:1995;83-90.
17. 2+ channels are located on somata, dendrites and a subpopulation of dendritic spines on live hippocampal pyramidal neurons. J. Neurosci. 14:1994;6815-6824.
18. Nadasdi L., Yamashiro D., Chung D., Tarczy-Hornoch K., Adriaenssens, Ramachandran J. Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channels. Biochemistry. 34:1995;8076-8081.
19. 2+ channels: more than stamp collecting? TiPS. 18:1997;363-371.
20. Olivera B. M., Cruz U., de Santos V., LeCheminant G. W., Griffin D., Zeikus R., McIntosh J. M., Galyean R., Varga J., Gray W. R., Rivier J. Neuronal calcium channel antagonists: discrimination between calcium channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry. 26:1987;2086-2090.
21. Olivera B. M., Gray W. R., Zeikus J. R., McIntosh J. M., Varga J.et al. Peptide neurotoxins from fish hunting cone snails. Science. 203:1985;1338-1343.
22. Olivera B. M., Rivier J., Clark C., Ramilo C. A., Corpuz G. P., Abogadie F. C., Mena E. E., Woodward S. R., Hillyard D. R., Cruz U. Diversity of Conus neuropeptides. Science. 249:1990;257-263.
23. Olivera B. M., Rivier J., Scott J. K., Hillyard D. R., Cruz U. Conotoxins. J. Biol. Chem. 266:1991;22067-22070.
24. Olivera B. M., Miljanich G. P., Ramachandran J., Adams M. E. Calcium channel diversity and neurotransmitter release: the omega-cenotoxins and omega-agatoxins. Ann Rev. Biochem. 63:1994;823-867.
25. Pulsinelli W. A., Brierley J. B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 10:1979;267-272.
26. Ramachandran, J., Nadasdi, L., Gohil, K., Kristipati, R., Tarczy-Hornoch, K., Gaur, S., Singh, T., Bell, J. and Miljanich, G. (1993) Novel conopeptides reveal neuronal calcium channel diversity. In Perspectives in Medicinal Chemistry, eds. Bernard Testa et al., pp. 374-388. Weinheim, Basal, Switzerland.
27. Siesjö, B., Kristián, T. and Katsura, K. (1995) The role of calcium in delayed postischemic brain damage. In Cerebrovascular Diseases, Nineteenth Princeton Stroke Conference 1994, eds. M. Moskowitz and L. Capalan, pp. 353-370, Butterworth-Heinemann, Boston.
28. Siesjö B. K. Calcium and ischemic brain damage. Eur. Neurol. 25:1986;45-56.
29. Smith, M.-L. and Siesjo, B. K. (1992) Postischemic treatment with omega-conopeptide SNX-111 protects the rat brain against ischemic damage. In Pharmacology of Cerebral Ischemia, eds. J. KriegIstein and H. Oberpilcher-Schwenk, pp. 162-167. Wissenschaftliche Verlag, Stuttgart.
30. Stevens C. W., Yaksh T. L. Potency of infused spinal antinociceptive agents is inversely related to the magnitude of tolerance after continuous infusion. J. Pharmacol. Exp. Ther. 250:1989;1-8.
31. Valentino K., Newcomb R., Gadbois T., Singh T., Bowersox S., Bitner S., Justice A., Yamamoto D., Hoffman B. B., Ciaranello R., Miljanich G., Ramachandran J. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7894-7897.
32. 2+ entry blockers. Ann. N. Y. Acad. Sci. 522:1988;478-490.